In patients with high bleeding risk, 1 vs. ≥3 mo of DAPT after complex or noncomplex PCI did not differ for clinical events
- PMID: 36191320
- DOI: 10.7326/J22-0076
In patients with high bleeding risk, 1 vs. ≥3 mo of DAPT after complex or noncomplex PCI did not differ for clinical events
Abstract
Valgimigli M, Smits PC, Frigoli E, et al. Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis. Eur Heart J. 2022:43:3100-14. 35580836.
Comment on
-
Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis.Eur Heart J. 2022 Sep 1;43(33):3100-3114. doi: 10.1093/eurheartj/ehac284. Eur Heart J. 2022. PMID: 35580836 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous